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CASE REPORT
CLINICAL CASEPulmonary Artery Pressure
Ventricularization in a Patient With
Carcinoid Heart Disease
Marius Reto Bigler, MD, Lukas Hunziker, MD, Stefano Fausto de Marchi, MD, Thomas Pilgrim, MD,
Stephan Windecker, MD, Christian Seiler, MDABSTRACTL
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MaVentricularization of the pulmonary artery pressure curve is shown, characterized by a steep diastolic pressure fall with
mid-diastolic pressure equalization with the right ventricle, which was caused by severe pulmonary valvular regurgitation
in a patient with carcinoid heart syndrome. (Level of Difficulty: Beginner.) (J Am Coll Cardiol Case Rep 2020;2:1200–4)
© 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A 72-year-old man was referred for furtherdiagnostic workup because of progressivedyspnea, recurrent symptomatic ascites,
and renal failure on September 6, 2019. At admission,
the patient was in reduced general condition and had
pronounced dyspnea (New York Heart Association
functional class IV) and orthopnea. Vital signs on pre-
sentation: temperature: 35.8C; pulse: 63 beats/min;
blood pressure 111/56 mm Hg; respiratory rate: not
documented. Blood analysis revealed increased
levels of N-terminal pro–B-type natriuretic peptideEARNING OBJECTIVES
To understand the high adaptive capacity of
the right ventricle in tolerating massive
volume overload caused by free pulmonary
valve regurgitation.
To consider carcinoid heart syndrome as the
cause of massive pulmonary valve regurgi-
tation aside from pulmonary valve stenosis.
N 2666-0849
m the Department of Cardiology, Inselspital, Bern University Hospital,
orted that they have no relationships relevant to the contents of this pap
e authors attest they are in compliance with human studies committe
titutions and Food and Drug Administration guidelines, including patien
it the JACC: Case Reports author instructions page.
nuscript received December 2, 2019; revised manuscript received April 2(8.523 pg/ml), renal retention parameters (creatinine:
291 mmol/l) and pathologic hepatic enzymes
(g-glutamyltransferase: 183 U/l; alkaline phospha-
tase: 328 U/l).
PAST MEDICAL HISTORY
The patient was first diagnosed in 2007 with a
neuroendocrine tumor of the small intestine
(pT3 pN1, L1 V0 G1) with hepatic metastases; diag-
nosis was followed by immediate resection of the
primary tumor. Subsequently, he underwent several
cycles of medical therapy with octreotide, ever-
olimus, and lanreotide, resulting in a stable,
progression-free state according to the oncologist in
charge. In June 2017, severe tricuspid valve regurgi-
tation as the first manifestation of carcinoid heart
syndrome led to tricuspid valve replacement surgery
using a biological valve prosthesis. Transthoracic
echocardiography of the other cardiac valves showed
only mild structural alterations at that time.https://doi.org/10.1016/j.jaccas.2020.05.057
University of Bern, Switzerland. The authors have
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es and animal welfare regulations of the authors’
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AB BR E V I A T I O N S
AND ACRONYM S
LV = left ventricle
PA = pulmonary artery
PAP = pulmonary artery
pressure
RV = right ventricle
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1201DIFFERENTIAL DIAGNOSIS
In July 2019, transthoracic echocardiography revealed
a good surgical result without residual tricuspid
regurgitation. Furthermore, a dilated right ventricle
(RV) with severely impaired systolic function and left
ventricular (LV) infero-posterolateral thickening of
the pericardium was visualized. Together with the
known episodes of ascites, post-operative constric-
tive pericarditis was suspected with right heart fail-
ure in the context of the preceding tricuspid
regurgitant RV volume overload.
INVESTIGATIONS
Accordingly, left and right heart catheterization was
performed for evaluation of the hemodynamic situa-
tion. Even after fluid challenge (approximately 1 l),
the diagnosis of constrictive pericarditis could not be
confirmed hemodynamically. Pulmonary artery (PA)
pressure (PAP) was significantly increased (mean
PAP: 34 mm Hg), and the phasic PAP curve was
entirely congruent with the phasic RV pressure curve
upon catheter pullback (Figure 1A). Thus, there was a
complete loss of function of the pulmonary valve
with free regurgitation.
In this context, the steep diastolic blood pressure
decrease was caused by the unconstrained regurgi-
tation followed by PA-RV pressure equilibrium and aFIGURE 1 Pulmonary Artery Pressure Ventricularization
(A) Recording of the pressure curve in the pulmonary artery with pullba
morphology of the pulmonary artery pressure curve because of the comp
transthoracic echocardiography, showing a triphasic continuous-wave Do
contraction phase.subsequent mid-diastolic pressure increase
once RV compliance was exhausted. These
particular hemodynamics were alternatively
imaged by continuous-wave Doppler echo-
cardiography (Figure 1B, Video 1), which
shows early diastolic termination of the
regurgitant flow velocity signal. Late diastolic
atrial contraction was imaged by continuous-
wave Doppler as the flow velocity signal having the
same direction as RV ejection (i.e., a-wave). Accord-
ingly, the evidence of the a-wave in the PA verified
the loss of function of the pulmonary valve.
The hemodynamic situation was modeled by using
a hemodynamic simulator (1). The combination of
free pulmonary valve regurgitation with impaired RV
diastolic relaxation, in the absence of tricuspid valve
regurgitation and preserved right atrial function,
produced identical RV and PA phasic pressure curves
as well as the biphasic diastolic flow signal in the PA
(Figures 2B and 2C). In addition, RV volume overload
caused impaired LV filling due to ventricular inter-
dependence resulting in systemic sequelae, such as
chronic pre-renal kidney failure.
MANAGEMENT
Because of the patient’s refusal of another surgical
intervention, transcatheter pulmonary valve
implantation was successfully performed by ack of the catheter into the right ventricle (marked by an arrow). Please note the ventricular
lete loss of function of the pulmonary valve. (B) The pressure measurement was confirmed by
ppler signal in the pulmonary artery referring to the ejection, the regurgitation, and the atrial
FIGURE 2 Hemodynamic Simulation Using an Online Software (1)
(A) Pressure-volume loops of the right and left ventricles (RV and LV), including lines for the end-systolic pressure-volume relationship (end-
systolic elastance) and end-diastolic pressure-volume relationship (ventricular compliance). The loops in gray represent the hemodynamic
situation of a healthy person. (B) Pressure curves of the right ventricle (RVP), the right atrium (RAP), and the pulmonary artery (PAP). Please
note the early diastolic pressure equalization. (C) Flow pattern through the tricuspid valve (TVF) and in the pulmonary artery (PAF). As an
expression of the mid-diastolic pressure equalization between the RV and pulmonary artery, PAF in the same period oscillates around 0.
(D) Electrocardiogram, lead II.
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1202balloon-expandable biological valve (Edwards Sa-
pien 3, 29 mm, Edwards Lifesciences, Irvine,
California).
After pulmonary valve prosthesis implantation,
recording of the PAP revealed immediate normaliza-
tion and a decrease in mean PAP (Figure 3). Catheter
pullback into the RV showed an unchanged RV pres-
sure curve and mild pulmonary stenosis, with a peak-
to-peak gradient of 11 mm Hg, as an expression of still
augmented-RV stroke volume (i.e., a functional
stenosis).DISCUSSION
The presented case shows rapidly progressive carci-
noid heart disease despite extended oncological
therapy, tricuspid valve replacement for severe
insufficiency, and symptomatic treatment for
recurrent right heart failure. The reason for this
course of events is disease progression involving the
pulmonary valve, culminating in its functional
absence with PAP (right) ventricularization. In carci-
noid syndrome, high plasma levels of vasoactive
FIGURE 3 Normalization of the PAP Curve Immediately After Prosthesis Implantation
Recording of the pressure curve in the pulmonary artery after implantation of the bioprosthesis with pullback of the catheter into the right ventricle; the beginning of
the pullback is marked by an arrow. Please note the immediately normalized pulmonary artery pressure curve morphology, including the notching at the beginning of
the diastole as well as a continuously diastolic decrease of the pressure. ECG ¼ electrocardiogram.
TABLE 1 Summary of the Expert Statement (2)
Biomarkers for heart involvement in carcinoid syndrome
 N-terminal pro–B-type natriuretic peptide, cutoff level: 260 pg/ml
 Plasma/urinary 5-hydroxyindoleacetic acid (metabolization product of serotonin)
Diagnostic imaging modalities
 Transthoracic echocardiography (gold standard)
Optionally including advanced echocardiographic techniques (3-dimensional)
 Cardiac computed tomography
Assessment of the degree of structural valvular damage, pre-surgical assessment
 Cardiac magnetic resonance imaging
Quantification of ventricular volumes, impaired echocardiographic quality
Treatment
 Pharmacotherapy for heart failure
 Control of carcinoid syndrome symptoms
Gold standard: long-acting formulations of somatostatin analogues (octreotide and
lanreotide)
 Surgical management of carcinoid heart disease
Primarily valve replacement with adequate pre-surgical assessment, including renal,
liver, and lung function tests
 Percutaneous catheter-based interventions in high-risk patients with severe carcinoid
heart disease
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1203substances such as serotonin, prostaglandins, and
histamine cause mitogenic effects on fibroblasts and
smooth muscle cells, resulting in plaque-like de-
positions on the endocardial surfaces of valves and
the subvalvular apparatus (2). The spectrum of these
pathological modifications stretches from function-
ally negligible, mild valvular thickening to complete
fixation of valvular leaflets and cusps. Because of
pulmonary inactivation of the vasoactive substances,
right heart valves are predominantly affected, except
for patients with right-left shunts (e.g., persistent
foramen ovale) (2).
Concerning the optimal treatment of patients with
carcinoid heart disease, an expert statement is avail-
able from the International Symposium for Carcinoid
Heart Disease held in 2014 in London, United
Kingdom (2) (summary listed in Table 1).
The high adaptive capacity of the RV to the
massive volume overload caused by free pulmonary
valve regurgitation is remarkable. Today, such clin-
ical cases are rare because of improved diagnostic
methods, and they are mostly restricted to the right
side of the heart. Historically, rare cases of very se-
vere aortic valve regurgitation with late-diastolic
aortic valve opening in response to left atrial
contraction following arterial and LV pressure
equalization have been described (3).However, our case is special with regard to the
underlying carcinoid heart syndrome, which func-
tionally dissolved the pulmonary valve. Thus, severe
pulmonary valve regurgitation caused diastolic
elastic recoil of the overdistended RV myocardium as
a probable mechanism for the mid-diastolic pressure
increase, which followed PA-RV pressure equilibra-
tion. Preserved right atrial function induced the end-
Bigler et al. J A C C : C A S E R E P O R T S , V O L . 2 , N O . 8 , 2 0 2 0
Pulmonary Artery Pressure Ventricularization J U L Y 2 0 2 0 : 1 2 0 0 – 4
1204diastolic antegrade pressure /flow velocity wave, the
detection of which in the pulmonary trunk proves,
on its own, complete absence of pulmonary valvular
function.
FOLLOW-UP
The day after prosthesis implantation, transthoracic
echocardiography revealed correct positioning with
mild paravalvular regurgitation along with the
known pressure gradient across the prosthesis
(Video 2). Respiratory variability of the inferior vena
cave suggested normal central venous pressure (5 to
10 mm Hg). Three days later, the patient described a
significant improvement of his condition and was
referred for cardiac rehabilitation. During rehabili-
tation, the patient expressed being exhausted from
medical treatment and his wish to die. Afterextensive discussion with his spouse and relatives,
oral medication was stopped, and palliative care was
introduced. The patient died 2 months later.
CONCLUSIONS
Functional absence of the pulmonary valve caused by
carcinoid heart disease resulted in free pulmonary
regurgitation, causing phasic PAP to merge with RV
pressure, that is, to completely ventricularize. This
situation, although compatible with life, causes
multiple organ dysfunction based on impaired LV
filling with insufficient stroke volume.
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